Genes involved in cytoskeletal stability and trafficking, such as MAPT and SNCA, are important risk factors for Parkinson’s disease (PD). Two members of the cytoskeletal Septin family, SEPT4 and SEPT5, were implicated in PD pathobiology. We aimed to determine whether Septin genes are associated with Parkinson’s disease. To this end, six SNPs located in four different Septin loci were analyzed in 720 PD patients and 740 controls, all of Ashkenazi–Jewish origin. In addition, SEPT14 was sequenced and its expression was determined in different human tissues. Our results revealed that two SNPs in the SEPT14 locus, rs11981883 and rs10241628, were associated with a reduced risk for PD (p = 0.02 and p = 0.005). A third SNP, rs77231105, was localized in the putative promoter of SEPT14 and was predicted to affect the binding of the transcription factor Nkx2.5. This SNP was also associated with a reduced risk for PD (OR = 0.28, p < 0.0007). The three SEPT14 SNPs defined a protective haplotype which significantly reduced the risk for PD by 4-fold (p = 0.002). SEPT14 was found to be expressed in the brain and in the Substantia Nigra. These results suggest that SEPT14 may have a protective role in Parkinson’s disease pathogenesis, yet more studies are necessary to validate these results.
Parkinson’s disease Septin 14 SEPT14 Genetics
This is a preview of subscription content, log in to check access.
This work was supported by Tel Aviv Sourasky Medical Center Grant of Excellence, by the Kahn Foundation, by the Chief Scientist of the Israeli Ministry of Health (grant no. 3-4893), by the Legacy Heritage Biomedical Science Partnership Program of the Israel Science Foundation (grant no.1922/08). This work was performed in partial fulfillment of the requirements for an M.Sc. degree of Liron Rozenkrantz, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Compliance with Ethical Standards
Conflict of Interest
All authors report no actual or potential conflict of interests.
Ageta-Ishihara N, Miyata T, Ohshima C, et al. (2013) Septins promote dendrite and axon development by negatively regulating microtubule stability via HDAC6-mediated deacetylation. Nat Commun 4:2532CrossRefPubMedPubMedCentralGoogle Scholar
Almeida MQ, Soares IC, Ribeiro TC, et al. (2010) Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. J Clin Endocrinol Metab 95(3):1458–1462CrossRefPubMedGoogle Scholar
Do CB, Tung JY, Dorfman E, et al. (2011) Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease. PLoS Genet 7(6):e1002141CrossRefPubMedPubMedCentralGoogle Scholar
Gan-Or Z, Bar-Shira A, Dahary D, et al. (2012) Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk. Arch Neurol 69(1):105–110CrossRefPubMedGoogle Scholar
Gaunt TR, Rodriguez S, Day IN (2007) Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool ‘CubeX’. BMC Bioinf 8:428CrossRefGoogle Scholar
Gilden J, Krummel MF (2010) Control of cortical rigidity by the cytoskeleton: emerging roles for septins. Cytoskeleton (Hoboken) 67(8):477–486Google Scholar
Ihara M, Tomimoto H, Kitayama H, et al. (2003) Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson’s disease and other synucleinopathies. J Biol Chem 278(26):24095–24102CrossRefPubMedGoogle Scholar
Ihara M, Yamasaki N, Hagiwara A, et al. (2007) Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity. Neuron 53(4):519–533CrossRefPubMedGoogle Scholar
International Parkinson Disease Genomics, C., Nalls MA, Plagnol V, et al. (2011) Imputation of sequence variants for identification of genetic risks for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet 377(9766):641–649CrossRefGoogle Scholar
Keller MF, Saad M, Bras J, et al. (2012) Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease. Hum Mol Genet 21(22):4996–5009CrossRefPubMedPubMedCentralGoogle Scholar
Lei P, Ayton S, Finkelstein DI, Adlard PA, Masters CL, Bush AI (2010) Tau protein: relevance to Parkinson’s disease. Int J Biochem Cell Biol 42(11):1775–1778CrossRefPubMedGoogle Scholar
Lill CM, Roehr JT, McQueen MB, et al. (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: the PDGene database. PLoS Genet 8(3):e1002548CrossRefPubMedPubMedCentralGoogle Scholar
Marttinen M, Kurkinen KM, Soininen H, Haapasalo A, Hiltunen M (2015) Synaptic dysfunction and septin protein family members in neurodegenerative diseases. Mol Neurodegener 10(1):16CrossRefPubMedPubMedCentralGoogle Scholar
Matarasso N, Bar-Shira A, Rozovski U, Rosner S, Orr-Urtreger A (2007) Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate. Neoplasia 9(9):707–715CrossRefPubMedPubMedCentralGoogle Scholar
Mostowy S, Cossart P (2012) Septins: the fourth component of the cytoskeleton. Nat Rev Mol Cell Biol 13(3):183–194PubMedGoogle Scholar
Nemani VM, Lu W, Berge V, et al. (2010) Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65(1):66–79CrossRefPubMedPubMedCentralGoogle Scholar
Rodriguez S, Gaunt TR, Day IN (2009) Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169(4):505–514CrossRefPubMedPubMedCentralGoogle Scholar
Russell SE, Hall PA (2011) Septin genomics: a road less travelled. Biol Chem 392(8–9):763–767PubMedGoogle Scholar
Satake W, Nakabayashi Y, Mizuta I, et al. (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease. Nat Genet 41(12):1303–1307CrossRefPubMedGoogle Scholar
Shinoda T, Ito H, Sudo K, Iwamoto I, Morishita R, Nagata K (2010) Septin 14 is involved in cortical neuronal migration via interaction with septin 4. Mol Biol Cell 21(8):1324–1334CrossRefPubMedPubMedCentralGoogle Scholar